Details for New Drug Application (NDA): 202960
✉ Email this page to a colleague
The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 202960
Tradename: | ATOVAQUONE |
Applicant: | Amneal Pharms |
Ingredient: | atovaquone |
Patents: | 0 |
Suppliers and Packaging for NDA: 202960
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATOVAQUONE | atovaquone | SUSPENSION;ORAL | 202960 | ANDA | Amneal Pharmaceuticals LLC | 65162-693 | 65162-693-88 | 1 BOTTLE in 1 CARTON (65162-693-88) / 210 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 750MG/5ML | ||||
Approval Date: | Mar 18, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription